| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
25,776,000 | 25,610,000 | 25,867,000 | 27,283,000 | 27,655,000 |
| Cost of Revenue
|
-4,238,000 | -4,226,000 | -4,436,000 | -4,641,000 | -4,554,000 |
|
Gross Profit
|
21,538,000 | 21,384,000 | 21,431,000 | 22,642,000 | 23,101,000 |
| Selling, General and Administrative Expenses
|
-4,391,000 | -4,203,000 | -3,981,000 | -3,859,000 | -4,173,000 |
|
Research and Development Expenses
|
-133,000 | -133,000 | -174,000 | -181,000 | -138,000 |
| Depreciation, Amortization and Depletion
|
-2,442,000 | -2,270,000 | -3,062,000 | -24,000,000 | -1,305,000 |
|
Taxes Other Than Income Taxes
|
15,000 | 15,000 | -449,000 | -49,000 | -12,000 |
| Other Income/Expense, Operating
|
-3,731,000 | -3,134,000 | -3,132,000 | -3,086,000 | -3,194,000 |
|
Operating Income/Expenses
|
-10,682,000 | -9,725,000 | -10,798,000 | -31,175,000 | -8,822,000 |
|
Total Operating Profit/Loss
|
10,856,000 | 11,659,000 | 10,633,000 | -8,533,000 | 14,279,000 |
| Total Net Finance Income/Expense
|
-1,164,000 | -1,730,000 | -1,588,000 | -1,720,000 | -1,592,000 |
| Net Investment Income
|
244,000 | 1,529,000 | 1,784,000 | 434,000 | 265,000 |
| Irregular Income/Expenses
|
-1,599,000 | -1,599,000 | -7,291,000 | -7,242,000 | -3,628,000 |
|
Non-Operating Income/Expenses, Total
|
-2,519,000 | -1,800,000 | -7,095,000 | -8,528,000 | -4,955,000 |
|
Pretax Income
|
8,337,000 | 9,859,000 | 3,538,000 | -17,061,000 | 9,324,000 |
| Provision for Income Tax
|
-1,909,000 | -2,094,000 | -357,000 | 2,872,000 | -2,478,000 |
|
Net Income from Continuing Operations
|
6,428,000 | 7,765,000 | 3,181,000 | -14,189,000 | 6,846,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
6,428,000 | 7,765,000 | 3,181,000 | -14,189,000 | 6,846,000 |
|
Non-Controlling/Minority Interests
|
14,000 | -1,000 | -113,000 | -178,000 | -180,000 |
|
Net Income after Non-Controlling/Minority Interests
|
6,442,000 | 7,764,000 | 3,068,000 | -14,367,000 | 6,666,000 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
-93,000 | -87,000 | -42,000 | -45,000 | -49,000 |
|
Net Income Available to Common Stockholders
|
6,349,000 | 7,677,000 | 3,026,000 | -14,412,000 | 6,617,000 |
|
Dilution to Earnings
|
0 | 0 | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
6,349,000 | 7,677,000 | 3,026,000 | -14,412,000 | 6,617,000 |
|
Common Dividend per Share
|
3.66 | 2.45 | 2.40 | 2.35 | 2.31 |
| Basic EPS
|
2.92 | 3.51 | 1.37 | -6.47 | 2.93 |
| Diluted EPS
|
2.91 | 3.49 | 1.36 | -6.47 | 2.92 |
|
Basic Weighted Average Shares Outstanding
|
2,172,500 | 2,187,000 | 2,214,000 | 2,229,000 | 2,256,000 |
|
Diluted Weighted Average Shares Outstanding
|
2,184,500 | 2,199,000 | 2,225,000 | 2,229,000 | 2,267,000 |
|
Reported Normalized Basic EPS
|
3.60 | 3.54 | 3.64 | 3.77 | 3.73 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade